Pineapple Express Launches AI Platform for OTC Public Companies

Synaps9 offers micro-cap issuers a full AI executive team for $999 per month

Apr. 13, 2026 at 6:54pm

Got story updates? Submit your updates here. ›

A highly detailed, glowing 3D macro illustration of a futuristic AI control panel or digital dashboard, with neon cyan and magenta lights illuminating the various modules and interfaces. The image conveys a sense of advanced, intelligent technology powering the autonomous management of a public company.Synaps9's AI-powered platform aims to revolutionize how micro-cap public companies manage their operations and shareholder communications.Atlanta Today

Pineapple Express Cannabis Company has launched Synaps9, a proprietary AI platform that deploys autonomous executive teams to manage the day-to-day operations of micro-cap public companies trading on OTC Markets. For $999 per month, each issuer receives six AI agents - an AI CEO, CFO, CMO, COO, CTO, and General Counsel - that handle SEC filings, shareholder communications, press releases, investor relations, email, website management, corporate governance, and compliance monitoring.

Why it matters

Over 12,000 companies trade on OTC Markets, and many struggle to maintain consistent shareholder communications, timely filings, and professional investor relations due to the high costs. Synaps9 aims to change the economics by providing a full AI-powered executive team to handle these critical functions at a flat monthly rate, potentially making it more accessible for micro-cap issuers.

The details

Synaps9 is built on a proprietary fork of the open-source Paperclip orchestration framework, with domain-specific skill files for EDGAR filing automation, OTC Markets compliance, and transfer agent reconciliation. The platform offers a white-label branded dashboard, live shareholder chat, and interactive demos to showcase its AI agent capabilities. Pineapple Express is positioning Synaps9 as the first vertical SaaS product purpose-built for the 11,000+ companies trading on OTC Markets.

  • Synaps9 officially launched on April 13, 2026.

The players

Pineapple Express Cannabis Company

A Nevada-incorporated, AI-managed public holding company headquartered in Atlanta, Georgia that develops and operates the Synaps9 platform.

Synaps9

Pineapple Express' proprietary AI platform that deploys autonomous executive teams to manage the day-to-day operations of micro-cap public companies trading on OTC Markets.

Frank Yglesias

The Chairman and CEO of Pineapple Express Cannabis Company.

Got photos? Submit your photos here. ›

What they’re saying

“Over 12,000 companies trade on OTC Markets, and the vast majority operate without consistent shareholder communications, timely filings, or professional investor relations infrastructure — not because they don't want to, but because the cost of maintaining that infrastructure has been prohibitive. Synaps9 changes the economics entirely.”

— Frank Yglesias, Chairman and CEO, Pineapple Express Cannabis Company

“Every issuer gets the full platform on day one. We deliberately chose a single-price model because micro-cap companies don't need sales complexity — they need their filings done on time, their shareholders informed, and their compliance current. Synaps9 handles all of that autonomously.”

— Frank Yglesias, Chairman and CEO, Pineapple Express Cannabis Company

What’s next

Pineapple Express is actively onboarding new OTC public company clients to the Synaps9 platform, with a focus on micro-cap issuers seeking to improve their shareholder communications, regulatory filings, and overall compliance.

The takeaway

Synaps9 represents an innovative approach to addressing the operational and compliance challenges faced by many micro-cap public companies on OTC Markets. By providing a full AI-powered executive team for a flat monthly fee, Pineapple Express aims to make professional management and investor relations more accessible, potentially benefiting both issuers and their shareholders.